Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgG allotypes and subclasses in Norwegian patients with multiple sclerosis.

G Raknes1, J A Fernandes Filho, J P Pandey

  • 1Department of Neurology, Haukeland Hospital, University of Bergen, N-502, Bergen, Norway.

Journal of the Neurological Sciences
|June 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation.

Case reports in immunology·2022
Same author

Microwave assisted synthesis of guar gum based biopolymeric macromolecule optimized as a flocculant for mineral ore processing.

International journal of biological macromolecules·2022
Same author

How often do nurses suspect violence and domestic violence in local emergency medical communication centre? A cross-sectional study.

Scandinavian journal of primary health care·2022
Same author

Suicide trends in Norway during the first year of the Covid-19 pandemic. A register-based cohort study.

European psychiatry : the journal of the Association of European Psychiatrists·2022
Same author

Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield.

Scientific reports·2022
Same author

The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018

This study found no significant link between IgG allotypes or subclass levels and multiple sclerosis (MS) susceptibility, severity, or progression in Norwegian patients. Genetic factors and immunoglobulin G (IgG) subclasses do not appear to play a major role in MS pathogenesis.

Area of Science:

  • Immunogenetics
  • Neurology
  • Human Genetics

Background:

  • Multiple sclerosis (MS) is a complex neurological disease influenced by genetic and environmental factors.
  • Investigating the genetic basis, specifically immunoglobulin G (IgG) allotypes and subclass levels, is crucial for understanding MS susceptibility and progression.

Purpose of the Study:

  • To investigate the association between IgG allotypes (GM and KM systems) and IgG subclass levels with MS susceptibility, severity, and disease course.
  • To determine the role of specific IgG allotypes in regulating serum IgG subclass concentrations in MS patients and healthy controls.

Main Methods:

  • Genotyping of 136 Norwegian MS patients and 92 controls for GM and KM IgG allotypes.
  • Quantification of IgG and IgG subclasses in sera from 115 MS patients and 20 controls.

Related Experiment Videos

  • Statistical analysis to correlate allotypes and subclass levels with clinical parameters of MS.

    • Main Results:

    • No significant correlation was found between GM or KM allotypes, or their genotypes, and MS susceptibility, severity, or disease course.
    • Specific allotypes (G1M(3), G2M(23), G3M(5)) were correlated with elevated IgG3 levels, and G1M(3), G2M(23) with elevated IgG2 levels in both patients and controls.
    • Serum IgG subclass levels showed no significant correlation with MS disease course or severity.

    Conclusions:

    • IgG allotypes and IgG subclass levels do not appear to play a major role in the pathogenesis of multiple sclerosis.
    • The investigated genetic markers and immunoglobulin profiles are unlikely to be significant determinants of MS development or progression.